Par Drugs Chemicals Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Par Drugs & Chemicals Ltd is ₹ 83.98 as of 18 May 15:30 . The p/e ratio of Par Drugs & Chemicals Ltd changed from 7.8 to 18.3 over 5 quarters. This represents a CAGR of 97.83% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Par Drugs & Chemicals Ltd changed from ₹ 104.5 crore to ₹ 265.1 crore over 5 quarters. This represents a CAGR of 110.59% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 19.97 crore as compare to the Dec '25 revenue of ₹ 30.67 crore. This represent the decline of -34.89% The revenue of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -100% The ebitda of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 1.8 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the decline of -75.64% The ebitda of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the decline of -100% The net profit of Par Drugs & Chemicals Ltd changed from ₹ 0.58 crore to ₹ 0.85 crore over 8 quarters. This represents a CAGR of 21.06% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Par Drugs & Chemicals Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani.
The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business.
With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Par Drugs & Chemicals Ltd or Procter & Gamble Health Ltd?

Market cap of Par Drugs & Chemicals Ltd is 103 Cr while Market cap of Procter & Gamble Health Ltd is 8,734 Cr

What are the key factors driving the stock performance of Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd?

The stock performance of Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd?

As of May 18, 2026, the Par Drugs & Chemicals Ltd stock price is INR ₹83.98. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5261.9.

How do dividend payouts of Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Par Drugs & Chemicals Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.